Causes and care for visible blood in children's urine in the pediatric emergency department
Official title: Causes and Management of Children Presenting With Macroscopic Hematuria in the Pediatric Emergency Department
Run by University Hospital, Strasbourg, France · NCT07312461 · Data updated 2026-11-12
This project will see how children under 18 with visible blood in their urine are diagnosed and treated in the pediatric emergency department to help create a standard care protocol.
Quick facts
| Study type | Observational |
|---|---|
| Ages | Any age to 17 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 1 site (Strasbourg) |
| Status | Recruiting |
| Started | September 30, 2024 |
| Main results expected | January 2026 |
| Study ends | January 2026 |
| Registry record updated | December 31, 2025 |
| Trial ID | NCT07312461 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children under 18 who present to the pediatric emergency department with visible (macroscopic) hematuria and whose parents or guardians consent to data collection.
✕Probably not a fit
Children whose hematuria is already explained and actively managed by another specialist, or those who decline participation, may not receive direct benefit from the study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study will enroll children under 18 who present to the pediatric emergency department at CHU de Strasbourg with macroscopic (visible) hematuria and collect clinical data on presentation, examinations, laboratory tests, imaging, diagnoses, treatments, and short-term outcomes. Investigators will record pathways of care, decision-making, and resource use to identify variability and common practices. No experimental treatments are given; data are collected from clinical evaluation and chart review, and participants or their parents can decline participation. Results will be used to propose a standardized emergency-department protocol to guide evaluation and management of pediatric macroscopic hematuria.
Why it matters
Potential benefit: If successful, the work could produce a standard ED protocol that reduces unnecessary tests, shortens time to diagnosis, and improves care consistency for children with visible blood in their urine.
How similar studies have gone: Few prior studies have described pediatric emergency management of macroscopic hematuria, so this approach is relatively understudied rather than widely proven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Minor subject (\<18 years old) * Patient presenting to the pediatric emergency department with gross hematuria Exclusion Criteria: \- Subject (and/or their parents) who expressed their opposition to participating in the study.
Where it's running
-
Service de Pédiatrie 1 - Réanimation - CHU de Strasbourg - France
Strasbourg, France Recruiting
Study contacts
- Study coordinator: Ariane ZALOSZYC, MD
- Email: ariane.zaloszyc@chru-strasbourg.fr
- Phone: 33 3 88 12 77 42
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.